{"id":86,"date":"2013-02-04T17:00:26","date_gmt":"2013-02-04T22:00:26","guid":{"rendered":"http:\/\/licensinglaw.net\/blog3\/?page_id=86"},"modified":"2021-04-12T08:35:18","modified_gmt":"2021-04-12T12:35:18","slug":"rehabilitating-existing-ip","status":"publish","type":"page","link":"https:\/\/licensinglaw.net\/blog3\/?page_id=86","title":{"rendered":"Rehabilitating Existing IP"},"content":{"rendered":"

Does your existing filing have a problematic flaw?\u00a0 Perhaps we can help: call us.\u00a0 A dermatology manufacturer did, and here’s what happened:<\/p>\n

\"The<\/a><\/p>\n

Ferndale Laboratories Inc. was the U.S. licensee for Yamanouchi’s Locoid\u00ae topical hydrocortisone 17-butyrate.\u00a0 Ferndale found a new, more stable (lotion) formulation, and filed a patent application on it.\u00a0 That application, however, had a number of drafting errors, leading the U.S. Patent Office to reject it several times over.\u00a0 Complicating matters, Glenmark Generics, Inc., a large generic manufacturer, published the fact that it had developed a manufacturing process to make Locoid\u00ae.<\/p>\n

At about this time,\u00a0Ferndale Laboratories decided to divest the product.<\/p>\n

The acquirer, Triax Pharmaceuticals LLC, asked us to assume responsibility for the IP.\u00a0 We reviewed the file and identified the source of the problem.\u00a0 We then designed a way to address it, fixing a problem with this\u00a0drug formulation patent application by using a tool used for biotechnology patent prosecution.<\/p>\n

\"\"<\/p>\n

The creative approach worked: 61 days after we became new attorneys of record, the Patent Office issued a Notice of Allowance.<\/em>\u00a0 The patent (US7378405<\/a>) was listed in the Orange Book<\/em> soon thereafter, protecting the new formulation from generics.<\/p>\n","protected":false},"excerpt":{"rendered":"

Does your existing filing have a problematic flaw?\u00a0 Perhaps we can help: call us.\u00a0 A dermatology manufacturer did, and here’s what happened: Ferndale Laboratories Inc. was the U.S. licensee for Yamanouchi’s Locoid\u00ae topical hydrocortisone 17-butyrate.\u00a0 Ferndale found a new, more stable (lotion) formulation, and filed a patent application on it.\u00a0 …<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":9,"menu_order":4,"comment_status":"closed","ping_status":"closed","template":"template-full-width.php","meta":{"footnotes":""},"class_list":["post-86","page","type-page","status-publish","hentry","column","twocol"],"_links":{"self":[{"href":"https:\/\/licensinglaw.net\/blog3\/index.php?rest_route=\/wp\/v2\/pages\/86","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/licensinglaw.net\/blog3\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/licensinglaw.net\/blog3\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/licensinglaw.net\/blog3\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/licensinglaw.net\/blog3\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=86"}],"version-history":[{"count":18,"href":"https:\/\/licensinglaw.net\/blog3\/index.php?rest_route=\/wp\/v2\/pages\/86\/revisions"}],"predecessor-version":[{"id":792,"href":"https:\/\/licensinglaw.net\/blog3\/index.php?rest_route=\/wp\/v2\/pages\/86\/revisions\/792"}],"up":[{"embeddable":true,"href":"https:\/\/licensinglaw.net\/blog3\/index.php?rest_route=\/wp\/v2\/pages\/9"}],"wp:attachment":[{"href":"https:\/\/licensinglaw.net\/blog3\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=86"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}